| DC Field | Value | Language |
|---|
| dc.contributor.author | Stupakova, E. G. | - |
| dc.contributor.author | Lazareva, G. A. | - |
| dc.contributor.author | Gureev, V. V. | - |
| dc.date.accessioned | 2022-04-27T15:30:26Z | - |
| dc.date.available | 2022-04-27T15:30:26Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Stupakova, E.G. Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil / E.G. Stupakova, G.A. Lazareva, V.V. Gureev // Research result: pharmacology and clinical pharmacology. - 2018. - Vol. 4, № 1.- P. 59-71. - Doi: 10.3897/rrpharmacology. 4.25528. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46416 | - |
| dc.description.abstract | Preeclampsia is one of the most serious diseases of the second half of pregnancy and is surely amongst the top three causes of maternal mortality. Therefore, the creation of new drugs for preventing and correcting preeclampsia is an urgent task | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | obstetrics | ru |
| dc.subject | pathological obstetrics | ru |
| dc.subject | pathology of pregnancy | ru |
| dc.subject | animal physiology | ru |
| dc.subject | resveratrol | ru |
| dc.subject | nicorandil | ru |
| dc.subject | preeclampsia | ru |
| dc.subject | pharmacological preconditioning | ru |
| dc.subject | K+ ATP channels | ru |
| dc.subject | rats | ru |
| dc.subject | ADMA | ru |
| dc.title | Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 4, № 1
|
